© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Offer came as markets recovered and volatility fell
Latest block this week in volatile conditions
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad

More articles/Ad

More articles

  • ABS
    The Federal Reserve announced on Thursday that it will allow inflation to run higher than the long running 2% target, a long awaited and historic shift in monetary policy that marks the start of a new era that will enable the Fed to keep rates low for longer.
  • Thomas Hugger has more than two decades of investment experience in frontier markets. Volatility is part of the job description. But he has never faced challenges like those unleashed by the Covid-19 pandemic.
  • UK shopping centre owner Intu Properties has fallen into administration, throwing into question the fate of £2.5bn of CMBS notes secured by its real estate.
  • SSA
    The European Commission has published proposals for allocating €87.3bn of its €100bn unemployment support programme SURE, the temporary Support to mitigate Unemployment Risks in an Emergency facility. Italy and Spain are set to receive the largest amounts.
  • A staggering amount of capital has been raised by the world’s airlines so far this year as the industry has suffered its worst crisis since 9/11 as a result of the Covid-19 pandemic.
  • French equity capital markets are having another subdued year. Just €8.77bn has been raised so far across IPOs, block trades, rights issues and convertible bonds, according to Dealogic data.